Are not expected to complete 6 cycles of chemotherapy 12. Are planned to receive yellow fever o r other live (attenuated) vaccines during the course of study (see concomitant medication section ) 3.3.3 Removal of patients from the trial, therapy or assessment If a pati ent has to be withdrawn from the trial, the principal investigator (PI) should be informed immediately. If there is a medical reason for the withdrawal, the patient should be followed until the condition has either resolved itself or is stable and the individual concerned is able to resume care by his/her physician.